JP Morgan Maintains Zeltiq Aesthetics Inc to Neutral with Price Target $35.00

Brokerage firm JP Morgan Maintains its rating on Zeltiq Aesthetics Inc(NASDAQ:ZLTQ). In a research note issued to the investors, the brokerage major Raises the price-target to $35.00 per share. The shares have been rated Neutral. The rating by JP Morgan was issued on Aug 9, 2016.

Zeltiq Aesthetics Inc (ZLTQ) shares turned negative on Wednesdays trading session with the shares closing down -0.07 points or -0.19% at a volume of 6,88,228. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $37.2094. The peak price level was also seen at $37.2094 while the days lowest was $36.51. Finally the shares closed at $36.84. The 52-week high of the shares is $39.46 while the 52-week low is $18.41. According to the latest information available, the market cap of the company is $1,460 M.

Zeltiq Aesthetics Inc(ZLTQ) last announced its earnings results on Aug 8, 2016 for Fiscal Year 2016 and Q2.Company reported revenue of $89.47M. Analysts had an estimated revenue of $79.68M. Earnings per share were $-0.12. Analysts had estimated an EPS of $-0.05.

Several Insider Transactions has been reported to the SEC. On Aug 8, 2016, Mark J Foley (President and CEO) sold 50,000 shares at $35.03 per share price.Also, On Aug 5, 2016, Keith J Sullivan (CCO, President, North America) sold 8,000 shares at $34.38 per share price.On Jul 12, 2016, Bradley Hauser (VP, Research and Development) sold 3,000 shares at $30.02 per share price, according to the Form-4 filing with the securities and exchange commission.

ZELTIQ Aesthetics Inc. is a medical technology company. The Company is focused on developing and commercializing products utilizing its controlled-cooling technology platform. Its commercial product the CoolSculpting System is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system to dermatologists plastic surgeons and aesthetic specialists and generates revenue from sales of its CoolSculpting system and from sales of consumables to its customers. Consumables are the CoolSculpting procedure packs that it sells which are needed to perform procedures using its CoolSculpting system. As of December 31 2014 it had an installed base of 3176 CoolSculpting systems installed across approximately 2688 practices across the world. As of December 31 2014 1.5 million CoolSculpting cycles had been shipped to its customers and distributors.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Zeltiq Aesthetics Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Zeltiq Aesthetics Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.